Home > Healthcare > Medical Devices > Diagnostic Devices > Automated Immunoassay Analyzers Market

Automated Immunoassay Analyzers Market Trends

Report ID: GMI1727
Published Date: May 2023
Report Format: PDF

Download Free Sample

Automated Immunoassay Analyzers Market Trends

Increasing prevalence of infectious diseases is one of the pivotal factors that is set to drive automated immunoassay analyzers market growth. Early detection of infectious diseases is important to reduce the possibility of severe damage to the body. Thus, accurate and precise screening of infections such as Hepatitis, influenza, STDs, and numerous other infections in minimal time is projected to be a major market growth factor. Furthermore, awareness of diseases has increased the disease diagnosis in early stages for preventing complications by undergoing diagnostic tests.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The size of automated immunoassay analyzers industry was valued at USD 16.9 billion in 2022 and will reach over USD 67.7 billion in 2032, attributed to the growing prevalence of infectious illnesses, novel product launches, and growing range of clinical use of immunoassay analyzers.

The chemiluminescence segment was worth USD 5.3 billion in 2022 as a result of the high accuracy and sensitivity of the diagnosis using low analyte concentration.

The hospital end-use segment is anticipated to witness a 14.7% CAGR from 2023 to 2032 owing to the rising number of people suffering from heart and lung disorders, increasing awareness levels, and facilitative reimbursement schemes.

North America automated immunoassay analyzers market is predicted to reach over USD 23.2 billion by 2032 propelled by the increasing prevalence of infectious diseases, different allergies, and cancer in the region.